vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1092Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWВЛИЯНИЕ ПРОБИОТИЧЕСКОЙ КУЛЬТУРЫ LACTOBACILLUS RHAMNOSUS GG НА ИММУННЫЙ ОТВЕТ ОРГАНИЗМАINFLUENCE OF PROBIOTIC CULTURE LACTOBACILLUS RHAMNOSUS GG (LGG) ON IMMUNE RESPONSE OF ORGANISMСуржикА.В.SurzhikA.V.ОАО «Компания Юнимилк», МоскваРоссияPublic Corporation «Company Unimilk», MoscowRussian Federation20092309201582Вопросы современной педиатрии5458Copyright © Суржик А., 20092009Суржик А.Surzhik A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1092ReferencesHatakka K., Saxelin M. Probiotics in intestinal and non-intestinal infectious diseases – clinical evidence. Curr. Pharm. Des. 2008; 14: 1351–1367.Hatakka K., Saxelin M. Probiotics in intestinal and non-intestinal infectious diseases – clinical evidence. Curr. Pharm. Des. 2008; 14: 1351–1367.Hooper L., Wong M. Thelin A. et al. Molecular analysis of commensal host microbial relationships in the intestine. Science. 2001; 291: 881–884.Hooper L., Wong M. Thelin A. et al. Molecular analysis of commensal host microbial relationships in the intestine. Science. 2001; 291: 881–884.Marteau P., Seksik P. Tolerance of probiotics and prebiotics. J. Clin. Gasroenterol. 2004; 38: 67–69.Marteau P., Seksik P. Tolerance of probiotics and prebiotics. J. Clin. Gasroenterol. 2004; 38: 67–69.Goldin B.R., Gorbach S.L., Saxelin M., et al. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 1992; 37 (1): 121–128.Goldin B.R., Gorbach S.L., Saxelin M., et al. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 1992; 37 (1): 121–128.Lim K. Antimicrobial susceptibility of Bifidobacteria. J. Dairy Sci. 1993; 76: 2168–2174.Lim K. Antimicrobial susceptibility of Bifidobacteria. J. Dairy Sci. 1993; 76: 2168–2174.Saxelin M. Safety of commercial products with viable Lactobacillus strains. Infec. Dis. Clin. Pract. 1996; 5: 331–335.Saxelin M. Safety of commercial products with viable Lactobacillus strains. Infec. Dis. Clin. Pract. 1996; 5: 331–335.Szajewska H., Kotovska M., Mrukowicz J. et al. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J. Pediatr. 2001; 138: 361–365.Szajewska H., Kotovska M., Mrukowicz J. et al. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J. Pediatr. 2001; 138: 361–365.Hatakka K., Savilahti E., Ponka A. et al., Effect of long term consumption of probiotic milk on infections in children attending day care centers: double blind, randomized trial. BMJ. 2001; 322: 1351–1367.Hatakka K., Savilahti E., Ponka A. et al., Effect of long term consumption of probiotic milk on infections in children attending day care centers: double blind, randomized trial. BMJ. 2001; 322: 1351–1367.Saxelin M. LGG – Summation: Lactobacillus GG and its health effects. Helsinki: Valio Lt. 2002. 60 p.Saxelin M. LGG – Summation: Lactobacillus GG and its health effects. Helsinki: Valio Lt. 2002. 60 p.Saavedra J.M., Long term consumption of infants formulas containing live probiotic bacteria: tolerance and safety. Am. J. Clin. Nutr. 2004; 79: 261–267.Saavedra J.M., Long term consumption of infants formulas containing live probiotic bacteria: tolerance and safety. Am. J. Clin. Nutr. 2004; 79: 261–267.Isolauri E., Suomalainen H. Probiotics: effects on immunity. Am. J. Clin. Nutr. 2001; 73: 444–450.Isolauri E., Suomalainen H. Probiotics: effects on immunity. Am. J. Clin. Nutr. 2001; 73: 444–450.Guandolini S. Lactobacillus GG administered in oral rehidratation solution to children with acute diarrhea. JPGN. 2000; 30: 54–60.Guandolini S. Lactobacillus GG administered in oral rehidratation solution to children with acute diarrhea. JPGN. 2000; 30: 54–60.Vanderhoof J.A., Whitney D.B., Antonson D.L. et al. Lactobacillus GG in the prevention of antibiotic-associated diarroea in children. J. Pediatr. 1999; 135: 564–568.Vanderhoof J.A., Whitney D.B., Antonson D.L. et al. Lactobacillus GG in the prevention of antibiotic-associated diarroea in children. J. Pediatr. 1999; 135: 564–568.Бельмер С.В., Хавкин А.И. Детская гастроэнтерология на компакт-диске. М.: Пасомар. 2003. 400 с.Бельмер С.В., Хавкин А.И. Детская гастроэнтерология на компакт-диске. М.: Пасомар. 2003. 400 с.Szajewska H., Skorka A., Ruszczynski M. et al., Meta-analysis: Lactobacillus GG for treating acute diarrhea in children. Aliment. Pharmacol. Ther. 2007; 25: 871–881.Szajewska H., Skorka A., Ruszczynski M. et al., Meta-analysis: Lactobacillus GG for treating acute diarrhea in children. Aliment. Pharmacol. Ther. 2007; 25: 871–881.Albers R., Antoine J. Bourdet-Sicard R. et al. Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 2005; 94: 452–481.Albers R., Antoine J. Bourdet-Sicard R. et al. Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 2005; 94: 452–481.Oberhelman R. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J. Pediatr. 1999; 134: 15–20.Oberhelman R. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J. Pediatr. 1999; 134: 15–20.Kekkonen R., Vasankari T., Vuorimaa T. et al. The effect of probiotic on respiratory infection and gastrointestinal symptoms during training in marathon runners. Int. J. Sport. Nutr. Exerc. Metab. 2007; 17: 352–363.Kekkonen R., Vasankari T., Vuorimaa T. et al. The effect of probiotic on respiratory infection and gastrointestinal symptoms during training in marathon runners. Int. J. Sport. Nutr. Exerc. Metab. 2007; 17: 352–363.Isolauri E., Joensuu J., Suomalainen H. et al. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus GG. Vaccine. 1995; 13: 310–312.Isolauri E., Joensuu J., Suomalainen H. et al. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus GG. Vaccine. 1995; 13: 310–312.De Vrese M., Winkler P., Rautenberg P. et al. Effect of Lactobacillus gasseri PA 16/18, Bifidobacterium longum SP 07/3. Clin. Nutr. 2005; 24: 481–491.De Vrese M., Winkler P., Rautenberg P. et al. Effect of Lactobacillus gasseri PA 16/18, Bifidobacterium longum SP 07/3. Clin. Nutr. 2005; 24: 481–491.Kaila M., Isolauri E., Saxelin M., et al. Viable versus inactivated Lactobacillus GG in acute rotavirus diarrhea. Arch. Dis. Child. 1995; 72: 51–53.Kaila M., Isolauri E., Saxelin M., et al. Viable versus inactivated Lactobacillus GG in acute rotavirus diarrhea. Arch. Dis. Child. 1995; 72: 51–53.Majamaa H., Isolauri E., Saxelin M., et al. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 1995; 20 (3): 333–338.Majamaa H., Isolauri E., Saxelin M., et al. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 1995; 20 (3): 333–338.Miettinen M., Lactobacilli and Streptococci activate NF–kappa B and STAT signaling pathways in human macrophages. J. Immunol. 2000; 1 (64): 253–258.Miettinen M., Lactobacilli and Streptococci activate NF–kappa B and STAT signaling pathways in human macrophages. J. Immunol. 2000; 1 (64): 253–258.Корниенко Е.А., Дроздова С.Н. Серебряная Н.Б. Пробиотики как способ повышения эффективности эрадикации Helicobacter pylori у детей. Фарматека. 2005; 7: 68–70.Корниенко Е.А., Дроздова С.Н. Серебряная Н.Б. Пробиотики как способ повышения эффективности эрадикации Helicobacter pylori у детей. Фарматека. 2005; 7: 68–70.Kalliomäki M., Salminen S., Poussa T., et al. Probiotics and prevention of atopic disease: 4year follow up of a randomized placebo controlled trial. Lancet. 2003; 361 (9372): 1869–1871.Kalliomäki M., Salminen S., Poussa T., et al. Probiotics and prevention of atopic disease: 4year follow up of a randomized placebo controlled trial. Lancet. 2003; 361 (9372): 1869–1871.Myllyluoma E. LGG and immune response. Helsinki: Valio Ltd. 2008.Myllyluoma E. LGG and immune response. Helsinki: Valio Ltd. 2008.
The authors declare that there are no conflicts of interest present.